EDVA Company Profile and Key Details

Average 10-day trading volume of 164.77 thousand shares is below the 3-month average of 184.50 thousand, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently within 5% of its 52-week low $0.23 and $13.40. With a market capitalization of about $1.56 million, Endovia Health Sciences, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.09). Key stats such as the average daily volume over the past year has been around 4.45 million shares, volume is running light vs its 52-week average. Headquartered in Fort Lauderdale, FL, Endovia Health Sciences, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Brady Cobb, the company employs approximately 2 people and listed since August 24, 2026. Endovia Health Sciences is a diversified cannabinoid-based health sciences platform.

Our AI price prediction model suggests that Endovia Health Sciences, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -30.33%, with price expected at $0.17 by September 24, 2026, within a range of $0.15 to $0.18 3-Month Outlook: Projected rise of 18.85%, reaching $0.29 by December 08, 2026, with a range of $0.25 to $0.34. 1-Year Outlook: Projected gain of 10.66%, with price at $0.27 by September 10, 2027, within a range of $0.00 to $0.00.

Our AI forecast model points to short-term weakness (-30.33% over two weeks), a medium-term rise (18.85% over three months), and a longer-term gain (10.66% over one year), with expected trading ranges indicating moderate volatility.